Inari Medical 주식 주식분석 | 주식가격 | 뉴스 | NARI | US45332Y1091 | A2P41U

날짜	Inari Medical 주식 가격
	41.61 undefined
	42.82 undefined
	40.63 undefined
	41.24 undefined
	41.20 undefined
	40.68 undefined
	41.48 undefined
	42.43 undefined
	43.17 undefined
	43.68 undefined
	43.84 undefined
	44.38 undefined
	44.10 undefined
	46.25 undefined
	46.52 undefined
	45.95 undefined
	45.07 undefined
	44.80 undefined
	44.64 undefined
	45.52 undefined
	41.68 undefined

날짜	Inari Medical 매출	Inari Medical EBIT	Inari Medical 이익
2028e	944.52 백만 undefined	0 undefined	0 undefined
2027e	1.01 조. undefined	60.38 백만 undefined	53.49 백만 undefined
2026e	847.92 백만 undefined	43.5 백만 undefined	39.76 백만 undefined
2025e	723.97 백만 undefined	3.93 백만 undefined	13.24 백만 undefined
2024e	612.19 백만 undefined	-25.39 백만 undefined	-43.93 백만 undefined
2023	493.63 백만 undefined	-3.63 백만 undefined	-1.64 백만 undefined
2022	383.5 백만 undefined	-28.1 백만 undefined	-29.3 백만 undefined
2021	277 백만 undefined	10.8 백만 undefined	9.8 백만 undefined
2020	139.7 백만 undefined	18.7 백만 undefined	13.8 백만 undefined
2019	51.1 백만 undefined	900,000 undefined	-1.2 백만 undefined
2018	6.8 백만 undefined	-9.1 백만 undefined	-10.2 백만 undefined

	매출	EBIT	이익
2018	6.8 백만 USD	-9.1 백만 USD	-10.2 백만 USD
2019	51.1 백만 USD	900,000 USD	-1.2 백만 USD
2020	139.7 백만 USD	18.7 백만 USD	13.8 백만 USD
2021	277 백만 USD	10.8 백만 USD	9.8 백만 USD
2022	383.5 백만 USD	-28.1 백만 USD	-29.3 백만 USD
2023	493.63 백만 USD	-3.63 백만 USD	-1.64 백만 USD
2024e	612.19 백만 USD	-25.39 백만 USD	-43.93 백만 USD
2025e	723.97 백만 USD	3.93 백만 USD	13.24 백만 USD
2026e	847.92 백만 USD	43.5 백만 USD	39.76 백만 USD
2027e	1.01 조. USD	60.38 백만 USD	53.49 백만 USD
2028e	944.52 백만 USD	0 USD	0 USD

2018	2019	2020	2021	2022	2023	2024e	2025e	2026e	2027e	2028e
0.01	0.05	0.14	0.28	0.38	0.49	0.61	0.72	0.85	1.01	0.94
-	750.00	172.55	99.28	38.27	28.72	24.14	18.14	17.15	18.77	-6.16
83.33	88.24	90.65	90.97	88.51	88.03	-	-	-	-	-
5	45	126	252	339	434	0	0	0	0	0
-9	0	18	10	-28	-3	-25	3	43	60	0
-150.00	-	12.95	3.61	-7.31	-0.61	-4.08	0.41	5.08	5.96	-
-10	-1	13	9	-29	-1	-43	13	39	53	0
-	-90.00	-1,400.00	-30.77	-422.22	-96.55	4,200.00	-130.23	200.00	35.90	-
46.1	46.1	49.3	55.6	52.8	56.77	0	0	0	0	0
-	-	-	-	-	-	-	-	-	-	-

2018	2019	2020	2021	2022	2023

21.8	23.6	164.2	176.1	326.4	115.45
2.2	11.3	28	42.4	58.6	70.12
0	0	0	0	0	0
1.1	4	10.6	21.1	32.6	42.9
0.9	0.6	2.9	5.7	5.3	7.09
26	39.5	205.7	245.3	422.9	235.56
0.9	3.3	7.5	61.4	72.4	69.34
0	0	0	4	8.3	1.5
0	0	0	0	0	0
0	0	0	0	0	150.88
0	0	0	0	0	214.34
0	1.8	0.9	1	0.6	2.62
0.9	5.1	8.4	66.4	81.3	438.67
26.9	44.6	214.1	311.7	504.2	674.24

54.2	54.2	0	0.1	0.1	0.06
1.4	2.1	227.6	257.1	462.9	504.45
-40.1	-41.2	-27.4	-17.6	-46.9	-48.49
-0.8	0	0	-0.4	0.8	8.89
0	0	0	0	0	0
14.7	15.1	200.2	239.2	416.9	464.91
0.7	2.5	3	6.5	7.7	10.58
1.4	6.3	10.8	36	48.5	65.76
0	0	0	0	0	0
0	0	0	0	0	0
0	0	0	0	0	0
2.1	8.8	13.8	42.5	56.2	76.34
9.8	19.5	0	0	0	0
0	0	0	0	0	36.23
0.2	1.2	0	29.8	31	96.76
10	20.7	0	29.8	31	132.99
12.1	29.5	13.8	72.3	87.2	209.33
26.8	44.6	214	311.5	504.1	674.23

2018	2019	2020	2021	2022	2023
-10	-1	13	9	-29	-1
0	0	1	3	4	6
0	0	0	0	0	0
-1	-6	-21	-14	-21	2
0	2	11	52	60	68
0	0	1,000	0	0	0
0	0	0	0	3	5
-10	-4	1	25	-13	35
0	-3	-5	-13	-9	-6
0	-3	-55	-51	-195	-58
0	0	-49	-37	-185	-51
0	0	0	0	0	0
0	9	-20	0	0	0
27	0	164	6	183	10
26	10	144	4	177	1
-	-	-	-2.00	-6.00	-9.00
0	0	0	0	0	0
15	2	90	-21	-32	-21
-11.64	-8.08	-3.55	11.84	-23.92	29.73
0	0	0	0	0	0

Inari Medical 브루토마진	Inari Medical 이익 마진	Inari Medical EBIT-마진	Inari Medical 이익 마진
2028e	88.03 %	0 %	0 %
2027e	88.03 %	6 %	5.32 %
2026e	88.03 %	5.13 %	4.69 %
2025e	88.03 %	0.54 %	1.83 %
2024e	88.03 %	-4.15 %	-7.18 %
2023	88.03 %	-0.74 %	-0.33 %
2022	88.4 %	-7.33 %	-7.64 %
2021	91.05 %	3.9 %	3.54 %
2020	90.69 %	13.39 %	9.88 %
2019	88.65 %	1.76 %	-2.35 %
2018	80.88 %	-133.82 %	-150 %

	브루토마진	EBIT-마진	이익 마진
2018	80.88 %	-133.82 %	-150 %
2019	88.65 %	1.76 %	-2.35 %
2020	90.69 %	13.39 %	9.88 %
2021	91.05 %	3.9 %	3.54 %
2022	88.4 %	-7.33 %	-7.64 %
2023	88.03 %	-0.74 %	-0.33 %
2024e	88.03 %	-4.15 %	-7.18 %
2025e	88.03 %	0.54 %	1.83 %
2026e	88.03 %	5.13 %	4.69 %
2027e	88.03 %	6 %	5.32 %
2028e	88.03 %	0 %	0 %

날짜	Inari Medical 주당 매출	Inari Medical EBIT 당 주식	Inari Medical 주당 이익
2028e	16.21 undefined	0 undefined	0 undefined
2027e	17.26 undefined	0 undefined	0.92 undefined
2026e	14.55 undefined	0 undefined	0.68 undefined
2025e	12.42 undefined	0 undefined	0.23 undefined
2024e	10.51 undefined	0 undefined	-0.75 undefined
2023	8.7 undefined	-0.06 undefined	-0.03 undefined
2022	7.26 undefined	-0.53 undefined	-0.55 undefined
2021	4.98 undefined	0.19 undefined	0.18 undefined
2020	2.83 undefined	0.38 undefined	0.28 undefined
2019	1.11 undefined	0.02 undefined	-0.03 undefined
2018	0.15 undefined	-0.2 undefined	-0.22 undefined

	주당 매출	EBIT 당 주식	주당 이익
2018	0.15 USD	-0.2 USD	-0.22 USD
2019	1.11 USD	0.02 USD	-0.03 USD
2020	2.83 USD	0.38 USD	0.28 USD
2021	4.98 USD	0.19 USD	0.18 USD
2022	7.26 USD	-0.53 USD	-0.55 USD
2023	8.7 USD	-0.06 USD	-0.03 USD
2024e	10.51 USD	0 USD	-0.75 USD
2025e	12.42 USD	0 USD	0.23 USD
2026e	14.55 USD	0 USD	0.68 USD
2027e	17.26 USD	0 USD	0.92 USD
2028e	16.21 USD	0 USD	0 USD

Segmente	2023
VTE	476.28 백만 USD
Emerging Therapies	17.36 백만 USD

	VTE	Emerging Therapies
2023	476.28 백만 USD	17.36 백만 USD

날짜	International	Other Countries	United States
2023	23.77 백만 USD	-	469.86 백만 USD
2022	-	9.43 백만 USD	374.04 백만 USD

	International	Other Countries	United States
2022	0 USD	9.43 백만 USD	374.04 백만 USD
2023	23.77 백만 USD	0 USD	469.86 백만 USD

	주식 수량
2018	46.1 백만 Aktien
2019	46.1 백만 Aktien
2020	49.3 백만 Aktien
2021	55.6 백만 Aktien
2022	52.8 백만 Aktien
2023	56.77 백만 Aktien
2024e	56.77 백만 Aktien
2025e	56.77 백만 Aktien
2026e	56.77 백만 Aktien
2027e	56.77 백만 Aktien
2028e	56.77 백만 Aktien

EPS-예상치	EPS-실제	보고 분기
-0.15	-0.38 (-154.01 %)	2024 Q2
-0.2	-0.22 (-7.79 %)	2024 Q1
0.01	-0.08 (-1,411.48 %)	2023 Q4
0	0.05 (1,011.11 %)	2023 Q3
-0.13	0.04 (131.01 %)	2023 Q2
-0.23	-0.04 (82.67 %)	2023 Q1
-0.17	-0.11 (37.03 %)	2022 Q4
-0.26	-0.19 (26.58 %)	2022 Q3
-0.23	-0.19 (19.01 %)	2022 Q2
-0.09	-0.06 (35.83 %)	2022 Q1
0.03	0.02 (-24.53 %)	2021 Q4
-0.11	-0.06 (46.52 %)	2021 Q3
0.08	0.07 (-15.97 %)	2021 Q2
0.05	0.13 (146.68 %)	2021 Q1
0.01	0.13 (855.88 %)	2020 Q4
-0.04	0.12 (409.28 %)	2020 Q3
-0.18	-0.16 (11.21 %)	2020 Q2

%-지분	이름	주식	변경
8.62824 %	The Vanguard Group, Inc.	5,027,677	325,586
7.83135 %	Wellington Management Company, LLP	4,563,325	-532,811
4.85964 %	Milder Community Property Trust	2,831,714	-143,900
4.44768 %	Longview Asset Management, L.L.C.	2,591,665	0
4.08380 %	AllianceBernstein L.P.	2,379,629	-18,632
3.74350 %	Millennium Management LLC	2,181,337	1,629,549
3.15936 %	State Street Global Advisors (US)	1,840,961	82,262
2.92108 %	Brown Advisory	1,702,113	255,182
2.01337 %	Geode Capital Management, L.L.C.	1,173,188	54,290
2.00874 %	Credit Suisse Funds AG	1,170,494	14,053
10.41846 %	BlackRock Institutional Trust Company, N.A.	6,070,839	252,742
1.78652 %	JP Morgan Asset Management	1,041,003	-117,996
1.67194 %	Hoffman (William H)	974,238	-3,514
1.66724 %	Templeton Investment Counsel, L.L.C.	971,500	0
1.32711 %	Voya Investment Management LLC	773,306	276,835
1.21069 %	Franklin Equity Group	705,471	192
1.20739 %	Point72 Asset Management, L.P.	703,549	460,969
1.06968 %	Franklin Advisers, Inc.	623,304	-11,903
1.04711 %	Baron Capital Management, Inc.	610,152	52,215
1.02284 %	Dimensional Fund Advisors, L.P.	596,007	41,555
1.01282 %	Nuveen LLC	590,173	21,814
1.00961 %	Northern Trust Investments, Inc.	588,298	7,479
0.97351 %	Principal Global Investors (Equity)	567,266	107,622
0.95280 %	Fiera Capital Corporation	555,197	-5,559
0.92161 %	Root (Jonathan D)	537,023	0
0.90098 %	Franklin Templeton Australia Limited	525,000	0
0.88651 %	American Century Investment Management, Inc.	516,572	93,402
0.88024 %	Eventide Asset Management, LLC	512,914	0
0.87715 %	Boston Management and Research	511,116	0
0.86037 %	Brown Capital Management, LLC	501,335	-1,256
0.78167 %	Fred Alger Management, LLC	455,477	-44,512
0.78094 %	JPMorgan Asset Management U.K. Limited	455,051	353,889
0.77958 %	Norges Bank Investment Management (NBIM)	454,262	-708,793
0.76113 %	Jennison Associates LLC	443,509	33,419
0.74326 %	Franklin Templeton Institutional, LLC	433,100	3,100
0.71735 %	Slate Path Capital LP	418,000	418,000
0.69681 %	Charles Schwab Investment Management, Inc.	406,033	5,986
0.65084 %	Hykes (Andrew J)	379,246	-4,222
0.60190 %	Marshall Wace LLP	350,728	-113,179
0.58518 %	T. Rowe Price Associates, Inc.	340,983	-833,640
0.57011 %	Point72 Europe (London) LLP	332,202	158,997
0.55673 %	MFS Investment Management	324,407	-94,884
0.53443 %	New York State Common Retirement Fund	311,410	29,983
0.50208 %	Tu (Thomas)	292,562	-2,119
0.46641 %	Jacobs Levy Equity Management, Inc.	271,776	271,776
0.46180 %	BlackRock Financial Management, Inc.	269,089	-11,460
0.43762 %	Milder (Donald B)	255,000	2,412
0.42374 %	BNY Mellon Asset Management	246,914	2,683
0.41843 %	CPR Asset Management	243,818	13,108
0.41282 %	Fuller & Thaler Asset Management Inc.	240,549	22,394
0.36781 %	Mellon Investments Corporation	214,325	5,337
0.36066 %	BlackRock Investment Management, LLC	210,156	8,772
0.31566 %	Balyasny Asset Management LP	183,937	183,937
0.30707 %	Squarepoint Capital LLP	178,931	104,017
0.30344 %	ClearBridge Investments, LLC	176,816	176,816
0.28361 %	Morgan Stanley & Co. LLC	165,259	-102,607
0.27950 %	Rhumbline Advisers Ltd. Partnership	162,862	-1,734
0.27871 %	BlackRock Advisors (UK) Limited	162,405	79,355
0.25542 %	Columbia Threadneedle Investments (US)	148,833	12,015
0.25090 %	CPP Investment Board	146,200	107,000
0.24520 %	ExodusPoint Capital Management, LP	142,878	59,478
0.24060 %	Renaissance Technologies LLC	140,199	-246,900
0.23614 %	Cubist Systematic Strategies, LLC	137,599	-30,627
0.22540 %	Motley Fool Wealth Management, LLC	131,340	-7,414
0.22226 %	Hill Mitch C	129,509	-2,067
0.22158 %	JPMorgan Private Bank (United States)	129,115	80,645
0.20999 %	Segall Bryant & Hamill, LLC	122,359	403
0.20028 %	Barclays Bank PLC	116,706	-132,013
0.19775 %	State of Wisconsin Investment Board	115,228	46,924
0.19142 %	Goldman Sachs & Company, Inc.	111,540	58,643
0.18460 %	Pier Capital, LLC	107,568	-1,617
0.17831 %	Macquarie Investment Management	103,900	23,411
0.17453 %	Schweizerische Nationalbank	101,700	-11,400
0.17161 %	Integral Health Asset Management, LLC	100,000	-250,000
0.16669 %	SEI Investments Management Corporation	97,131	-44,161
0.16357 %	SunAmerica Asset Management, LLC	95,311	-2,880
0.15016 %	Berry Street Capital Management LLP	87,500	-87,500
0.14612 %	PENN Capital Management Company, Inc.	85,146	85,146
0.13960 %	Wells Fargo Advisors	81,345	-2,048
0.13507 %	Legal & General Investment Management Ltd.	78,708	-50
0.13359 %	BofA Global Research (US)	77,845	-10,184
0.12930 %	Susquehanna International Group, LLP	75,344	5,299
0.12244 %	Two Sigma Investments, LP	71,344	-272,701
0.12208 %	Managed Account Advisors LLC	71,136	-34,563
0.11536 %	BlackRock Asset Management Ireland Limited	67,223	-1,073
0.11366 %	Goldman Sachs Asset Management, L.P.	66,228	-68,820
0.11001 %	The Retirement Systems of Alabama	64,100	366
0.10767 %	Evoke Advisors	62,740	0
0.10551 %	Nielsen (Kirk G)	61,479	0
0.10537 %	Jane Street Capital, L.L.C.	61,402	41,147
0.10518 %	Hightower Advisors, LLC	61,291	61,291
0.10442 %	Manulife Investment Management (North America) Limited	60,848	-39,909
0.10430 %	Essex Investment Management Company, LLC	60,775	-43,329
0.10374 %	Conestoga Capital Advisors, LLC	60,448	-1,642
0.10142 %	Candriam Luxembourg S.A.	59,095	0
0.09797 %	Parametric Portfolio Associates LLC	57,088	-22,150
0.09608 %	MetLife Investment Management, LLC	55,983	-378
0.09604 %	DWS Investments UK Limited	55,962	29,733
0.09595 %	Bridgewater Associates, LP	55,910	-5,109
0.09402 %	California State Teachers Retirement System	54,785	-2,524

What values and corporate philosophy does Inari Medical represent?

Inari Medical Inc is driven by a strong corporate philosophy and a set of core values that define its mission and operations. The company represents a commitment to innovation, patient-centric care, and continuous improvement in the field of medical devices. Inari Medical Inc firmly believes in transforming the lives of patients through its cutting-edge technologies, such as the FlowTriever and ClotTriever systems. With a focus on delivering safe and effective solutions for the treatment of venous and arterial diseases, Inari Medical Inc strives to enhance patient outcomes and provide healthcare professionals with reliable tools. By embracing a patient-first approach and fostering a culture of collaboration and excellence, Inari Medical Inc sets a high standard in the industry.

In which countries and regions is Inari Medical primarily present?

Inari Medical Inc is primarily present in the United States.

What significant milestones has the company Inari Medical achieved?

Inari Medical Inc has achieved several significant milestones since its inception. The company successfully went public in May 2020, listing its shares on the NASDAQ stock exchange under the ticker symbol "NARI". Inari Medical has also developed groundbreaking medical devices, including the FlowTriever and ClotTriever Systems, which offer minimally invasive solutions for the treatment of blood clots. These innovative products have received regulatory approvals and have been adopted by physicians worldwide. In addition, Inari Medical continues to experience rapid growth and expansion, establishing itself as a leader in the field of venous thromboembolism treatment.

What is the history and background of the company Inari Medical?

Inari Medical Inc, founded in 2011, is a leading provider of solutions for the treatment of venous diseases. The company specializes in developing innovative medical devices, particularly for treating blood clots and other vascular conditions. Inari's flagship product, the ClotTriever System, is a minimally invasive device used by physicians to remove clots from blocked vessels, providing a non-surgical alternative to traditional treatments. Inari Medical Inc has experienced significant growth since its inception, driven by the increasing demand for its cutting-edge technologies and a strong focus on improving patient outcomes. With their commitment to revolutionizing venous therapy, Inari Medical Inc continues to drive advancements in the field of vascular intervention.

Who are the main competitors of Inari Medical in the market?

The main competitors of Inari Medical Inc in the market include companies such as Penumbra Inc, Medtronic Plc, and AngioDynamics Inc.

In which industries is Inari Medical primarily active?

Inari Medical Inc is primarily active in the healthcare industry.

What is the business model of Inari Medical?

Inari Medical Inc is a medical device company with a unique business model. The company specializes in developing and commercializing innovative devices for the treatment of venous diseases, specifically deep vein thrombosis (DVT) and pulmonary embolism (PE). Inari Medical Inc's proprietary technologies and products aim to improve patient outcomes by providing minimally invasive solutions for the removal of blood clots. With a focus on research, development, and commercialization of cutting-edge medical devices, Inari Medical Inc aims to revolutionize the treatment of venous diseases and contribute to the improvement of patient care worldwide.

Inari Medical 2024의 P/E 비율은 얼마입니까?

Inari Medical의 P/E 비율은 -53.77입니다.

Inari Medical 2024의 KUV는 얼마입니까?

Inari Medical의 P/S 비율은 3.86입니다.

Inari Medical의 AlleAktien 품질 점수는 얼마인가요?

Inari Medical에 대한 AlleAktien 품질 점수는 2/10입니다.

Inari Medical 2024의 매출은 얼마인가요?

예상되는 Inari Medical 매출은 612.19 백만 USD입니다.

Inari Medical 2024의 이익은 얼마인가요?

예상되는 Inari Medical 이익은 -43.93 백만 USD입니다.

Inari Medical은 무엇을 하나요?

Inari Medical Inc. is one of the leading companies in the field of medical technology, focusing on the development and marketing of devices and products for the treatment of vascular and thromboembolic diseases. The business model of Inari Medical is based on the development and marketing of innovative products and services tailored to the needs of patients and physicians. The company operates in two main areas: venous diseases and pulmonary embolism. In the field of venous diseases, Inari Medical offers the ClotTriever System, a unique device for removing blood clots from the deep veins of the body. This system is a non-invasive alternative to traditional surgery, allowing for a minimally invasive procedure. It is a revolutionary procedure that offers benefits such as faster recovery time and high success rate. In the field of pulmonary embolism, Inari Medical has developed the FlowTriever System to remove blood clots from the pulmonary arteries. This system has proven to be effective and offers similar benefits to the ClotTriever System. Both systems are FDA approved and sold worldwide. Inari Medical has also developed a wide range of accessories and consumables to support these devices and improve treatment outcomes. In addition, Inari Medical also offers comprehensive training and education programs for physicians and medical personnel to ensure the safe and effective application of the systems. Inari Medical also has a strong patent portfolio, which has helped to increase its growth and success in the medical industry. The company has obtained several patents for its products and technologies and plans to further expand its portfolio through continuous research and development. Overall, the business model of Inari Medical Inc. has shown that the demand for innovative and effective solutions for the treatment of vascular and thromboembolic diseases is high. Through its reliable products and services, the company has solidified its position as a leading provider of medical technology in the market.

Inari Medical 배당금은 얼마입니까?

Inari Medical은(는) 연간 번의 배당을 통해 0 USD의 배당금을 지급합니다.

Inari Medical이 얼마나 자주 배당을 지급하나요?

Inari Medical의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Inari Medical ISIN이 무엇입니까?

Inari Medical의 ISIN은 US45332Y1091입니다.

Inari Medical WKN은 무엇인가요?

Inari Medical의 WKN은 A2P41U입니다.

Inari Medical 티커는 무엇인가요?

Inari Medical의 티커는 NARI입니다.

Inari Medical이 얼마만큼의 배당금을 지급합니까?

지난 12개월 동안 Inari Medical은(는) 의 배당금을 지급했습니다. 이는 약 의 배당 수익률에 해당합니다. 향후 12개월 동안 Inari Medical은(는) 0 USD의 배당금을 지급할 것으로 예상됩니다.

Inari Medical의 배당 수익률은 얼마입니까?

Inari Medical의 현재 배당 수익률은 입니다.

Inari Medical의 배당금은 언제 지급되나요?

Inari Medical은 분기별로 배당금을 지급합니다. 이는 월에 배당됩니다.

Inari Medical의 배당금은 얼마나 안전한가요?

Inari Medical은(는) 지난 0년 동안 매년 배당금을 지급했습니다.

Inari Medical의 배당금은 얼마입니까?

향후 12개월 동안 0 USD의 배당금이 예상됩니다. 이는 배당수익률 0 %에 해당합니다.

Inari Medical이(가) 속해 있는 섹터는 어디인가요?

Inari Medical은 '건강' 섹터에 속합니다.

Wann musste ich die Aktien von Inari Medical kaufen, um die vorherige Dividende zu erhalten?

Inari Medical의 마지막 배당금을 0 USD만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

Inari Medical의 마지막 배당금 지급일은 언제였습니까?

마지막 배당금 지급일은 입니다.

Inari Medical의 2023년도 배당금은 얼마였습니까?

2023년에 Inari Medical는 0 USD를 배당금으로 지급했습니다.

Inari Medical는 어떤 화폐로 배당금을 지급하나요?

Inari Medical의 배당금은 USD에 지급됩니다.

Scope 1 - 직접 방출	—
스코프 2 - 구매한 에너지로부터의 간접적인 배출	—
Scope 3 - 가치 창출 체인 내의 간접 배출	—
총 CO₂ 배출량	—
CO₂ 감소 전략	✅
석탄 에너지	❌
원자력	❌
동물 실험	❌
펠츠 & 레더	—
살충제	—
팜 오일	—
담배	❌
유전자 변형 생물체	❌
기후 개념	—
지속 가능한 임업	—
재활용 규정	❌
환경 친화적인 포장	❌
위험물질	❌
연료 소비량과 효율성	❌
물 사용량 및 효율성	❌

여성 직원 비율	42.72
관리 직위에서의 여성 비율	—
아시아 직원 비율	21.05
아시아 경영진 비율	—
히스패닉/라티노 직원 비율	18.58
히스패닉/라티노 관리 부문 지분	—
흑인 직원 비율	1.93
블랙 매니지먼트 지분	—
흰색 종업원의 비율	55.28
화이트 매니지먼트 지분	—
성인 콘텐츠	❌
알코올	❌
무기	—
총기	❌
도박	❌
군사 계약	❌
인권 개념	❌
개인정보 보호 정책	—
작업 및 건강 보호	✅
카톨릭	✅

환경 보고	❌
이해관계자 참여	❌
콜백 정책	❌
카르텔법	❌

증권거래소	Inari Medical 티커
뒤셀도르프	IM7.DU
프랑크푸르트	IM7.F
NASDAQ	NARI

Inari Medical 티커	Inari Medical FIGI
NARI:US	BBG009J8K7M0
NARI:UA	BBG00RVG46F6
NARI:UC	BBG00RVG46G5
NARI:UN	BBG00RVG46J2
NARI:UP	BBG00RVG46K0
NARI:UB	BBG00RVG46M8
NARI:UM	BBG00RVG46P5
NARI:UX	BBG00RVG46Q4
NARI:UD	BBG00RVG46W7
NARI:UW	BBG00RVG46Y5
NARI:UF	BBG00RVG46Z4
NARI:VY	BBG00RVG4700
NARI:VJ	BBG00RVG4719
NARI:VK	BBG00RVG4728
NARI:VF	BBG00RVG4737
NARI:VG	BBG00X1P9ZN8
NARI:VP	BBG00X1SRD15
NARIGBP:XH	BBG00ZXGW7G2
NARIGBP:XF	BBG00ZXGW7J9
NARIGBP:XE	BBG00ZXGW7L6
NARIGBP:XL	BBG00ZXGW7N4
NARIGBP:XG	BBG00ZXGW7P2
NARIGBP:XO	BBG00ZXGW7Q1
NARIGBP:XA	BBG00ZXGW7V5
NARIGBP:XT	BBG00ZXGW7X3
NARIGBP:XW	BBG00ZXGW7Y2
NARIGBP:XU	BBG00ZXGW7Z1
NARIGBP:XV	BBG00ZXGW816
NARIGBP:XM	BBG00ZXGW825
NARIGBP:EU	BBG00ZXGW898
NARIUSD:XH	BBG011N789W2
NARIUSD:XF	BBG011N789Y0
NARIUSD:XE	BBG011N78B02
NARIUSD:XL	BBG011N78B20
NARIUSD:XG	BBG011N78B39
NARIUSD:XO	BBG011N78B48
NARIUSD:XA	BBG011N78B84
NARIUSD:XT	BBG011N78BB0
NARIUSD:XW	BBG011N78BC9
NARIUSD:XU	BBG011N78BD8
NARIUSD:XV	BBG011N78BG5
NARIUSD:XM	BBG011N78BH4
NARIUSD:EU	BBG011N78BQ4
IM7:GR	BBG01JPJNDD0
IM7:GF	BBG01JPJNDG7
IM7:GD	BBG01JPJNDH6
IM7:GS	BBG01JPJNDK2
IM7:GB	BBG01JPJNDM0
IM7:GH	BBG01JPJNDQ6
IM7:LA	BBG01JPJNDZ6
IM7:LU	BBG01JPJNF09
NARIEUR:EO	BBG01JPW2836
NARIEUR:X2	BBG01JPW2845
NARIEUR:XH	BBG01JPW2863
NARIEUR:XF	BBG01JPW2881
NARIEUR:XE	BBG01JPW28B7
NARIEUR:XJ	BBG01JPW28C6
NARIEUR:XL	BBG01JPW28D5
NARIEUR:XG	BBG01JPW28F3
NARIEUR:XO	BBG01JPW28G2
NARIEUR:XA	BBG01JPW28L6
NARIEUR:E1	BBG01JPW28M5
NARIEUR:XT	BBG01JPW28N4
NARIEUR:XW	BBG01JPW28P2
NARIEUR:XU	BBG01JPW28Q1
NARIEUR:XY	BBG01JPW28R0
NARIEUR:XV	BBG01JPW28S9
NARIEUR:XM	BBG01JPW28T8
NARIEUR:XQ	BBG01JPW28V5
NARIEUR:XX	BBG01JPW28W4
NARIEUR:XZ	BBG01JPW28X3
NARIEUR:X1	BBG01JPW28Z1
NARIEUR:EU	BBG01JPW2916
IM7:TH	BBG01JRPTCZ6
IM7:QT	BBG01JRWP189

한 눈에 저평가된 주식을 인식하세요 fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Inari Medical 주식 주식과 주식 분석 Inari Medical ariva, Inari Medical onvista, Inari Medical finanzen.net, Inari Medical aktienfinder, Inari Medical marketscreener, Inari Medical marketwatch, Inari Medical bloomberg, Inari Medical handelsblatt, Inari Medical wiwo, Inari Medical forum

가격

가격

티커NARI

ISINUS45332Y1091

WKNA2P41U

Inari Medical 주식 가격

가격

개요

인트라데이 기능

총 수익률 및 상대 가격 변동

해석 및 투자

Inari Medical 주가 이력

Inari Medical 주식 매출, EBIT, 이익 US45332Y1091 · A2P41U

매출, 이익 & EBIT

매출, EBIT, 소득 이해하기

연간 분석 및 비교

투자 기대치 활용

투자 통찰력

Inari Medical 매출, 이익 및 EBIT 역사

Inari Medical 주식 지표

손익계산서

매출 성장

총 이익률

EBIT와 EBIT 마진

수입과 성장

발행 주식

연간 비교의 해석

기대치와 예측

재무 상태표

재무 상태표 이해

자산

부채

자본

년대비 분석

데이터 해석

Inari Medical 주식 마진 US45332Y1091 · A2P41U

마진

매출 총이익률 이해

EBIT 마진 분석

매출 마진에 대한 인사이트

기대치 해석

비교 분석

Inari Medical 마진 역사

Inari Medical 주식 매출, EBIT, 주당 순이익 US45332Y1091 · A2P41U

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Inari Medical 매출, 이익 및 EBIT 주당 역사

Inari Medical 주식 및 주식 분석

Inari Medical 매출 세분화 US45332Y1091 · A2P41U

세그먼트별 매출

세그먼트별 매출 개요

해석 및 사용

투자 전략

Inari Medical 매출 세분화

Inari Medical 지역별 매출 US45332Y1091 · A2P41U

세그먼트별 매출

지역별 매출 개요

해석 및 사용법

투자 전략

Inari Medical 매출 세분화

Inari Medical Fair Value에 따른 평가

Fair Value

Fair Value 이해하기

수익 기반 Fair Value

매출 기반 Fair Value

배당 기반 Fair Value

기대치와 예측

비교 분석

Inari Medical 역사적인 P/E, EBIT 및 P/S에 따른 평가

Inari Medical 주식 수량 US45332Y1091 · A2P41U

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

한 눈에 저평가된 주식을 인식하세요
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Inari Medical 주식
주식과 주식 분석 Inari Medical ariva, Inari Medical onvista, Inari Medical finanzen.net, Inari Medical aktienfinder, Inari Medical marketscreener, Inari Medical marketwatch, Inari Medical bloomberg, Inari Medical handelsblatt, Inari Medical wiwo, Inari Medical forum

티커
NARI

ISIN
US45332Y1091

WKN
A2P41U